BRAZIL
Challenging the industry To maintain the financial health serving the growing needs of investment in technology and development , Hertz explains that the company adheres to a strict policy of cost control without sacrificing growth and quality . “ Commercially speaking , as learned from the past , the trend is to keep growing and we must be oriented to take advantage of it . According to projections of the largest audit market , we have projected a doubledigit average growth for the sector that should make Brazil advance in the world ranking of the pharmaceutical market .”
The increase in regulatory and technical barriers were also cited by the president as factors that challenge the company with higher costs , need for investments and consequently , loss of productivity .
Market expansion As a consolidated commercial operation model , the company is focused on sales growth through market expansion and performance by increasing its portfolio . “ Over the past eight years , our revenue growth was above average in relation to the market ’ s based on our commercial expansion and portfolio increase ,” says Hertz .
The company ’ s investment focus in recent years has been turned to the development , technology and production areas , which also updated the SAP versions used since 2005 , and the implementation of the MES system —
Quality control
“ For 2015 , Kley Hertz intends to expand investments with funds financed through Finep , with projection of USD $ 10 million investment over the next three years ”
– President of Kley Hertz , Arthur Leite Hertz
www . kleyhertz . com . br 55